Center-Authored Papers

Filters: Author is Buchanan, Daniel D  [Clear All Filters]
Journal Article
Dashti GS, Buchanan DD, Jayasekara H, Ouakrim DA, Clendenning M, Rosty C, Winship IM, Macrae FA, Giles GG, Parry S et al..  2016.  Alcohol Consumption and the Risk of Colorectal Cancer in Mismatch Repair Gene Mutation Carriers.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Win AK, Hopper JL, Buchanan DD, Young JP, Tenesa A, Dowty JG, Giles GG, Goldblatt J, Winship I, Boussioutas A et al..  2013.  Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? European journal of cancer (Oxford, England : 1990). 49(7):1578-87. Abstract
Ouakrim DA, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B et al..  2015.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.. Journal of the National Cancer Institute. 107(9) Abstract
Campbell PT, Newton CC, Newcomb PA, Phipps AI, Ahnen DJ, Baron JA, Buchanan DD, Casey G, Cleary SP, Cotterchio M et al..  2015.  Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(8):1229-38. Abstract
Weisenberger DJ, Levine JA, Long TI, Buchanan DD, Walters R, Clendenning M, Rosty C, Joshi AD, Stern MC, Le Marchand L et al..  2015.  Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(3):512-9. Abstract
Phipps AI, Buchanan DD, Makar KW, Burnett-Hartman AN, Coghill AE, Passarelli MN, Baron JA, Ahnen DJ, Win AK, Potter JD et al..  2012.  BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(10):1792-8. Abstract
Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA, Clendenning M, Antill YC, Thibodeau SN, Casey G, Gallinger S et al..  2013.  Cancer Risks for MLH1 and MSH2 Mutation Carriers.. Human mutation. 34(3):490-7. Abstract
Win AK, Cleary SP, Dowty JG, Baron JA, Young JP, Buchanan DD, Southey MC, Burnett T, Parfrey PS, Green RC et al..  2010.  Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer.. International journal of cancer. Journal international du cancer. Abstract
Heath JA, Reece JC, Buchanan DD, Casey G, Durno CA, Gallinger S, Haile RW, Newcomb PA, Potter JD, Thibodeau SN et al..  2015.  Childhood cancers in families with and without Lynch syndrome.. Familial cancer. 14(4):545-551. Abstract
Shang J, Reece JC, Buchanan DD, Giles GG, Figueiredo JC, Casey G, Gallinger S, Thibodeau SN, Lindor NM, Newcomb PA et al..  2016.  Cholecystectomy and the risk of colorectal cancer by tumor mismatch repair deficiency status.. International journal of colorectal disease. 31(8):1451-7. Abstract
Levine JA, Phipps AI, Baron JA, Buchanan DD, Ahnen DJ, Cohen S, Lindor NM, Newcomb PA, Rosty C, Haile RW et al..  2015.  Clinicopathological risk factor distributions for MLH1 promoter region methylation in CIMP positive tumors.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Win AK, Young JP, Lindor NM, Tucker KM, Ahnen DJ, Young GP, Buchanan DD, Clendenning M, Giles GG, Winship I et al..  2012.  Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(9):958-64. Abstract
Kastrinos F, Ojha RP, Leenen C, Alvero C, Mercado RC, Balmaña J, Valenzuela I, Balaguer F, Green R, Lindor NM et al..  2016.  Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer.. Journal of the National Cancer Institute. 108(2) Abstract
Clendenning M, Walsh MD, Gelpi JB, Thibodeau SN, Lindor N, Potter JD, Newcomb P, Le Marchand L, Haile R, Gallinger S et al..  2013.  Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything? Familial cancer. 12(3):563-6. Abstract
Chau R, Jenkins MA, Buchanan DD, Ouakrim DA, Giles GG, Casey G, Gallinger S, Haile RW, Le Marchand L, Newcomb PA et al..  2016.  Determining the familial risk distribution of colorectal cancer: a data mining approach.. Familial cancer. 15(2):241-251. Abstract
Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, Conti DV, Qu C, Jeon J, Edlund CK et al..  2018.  Discovery of common and rare genetic risk variants for colorectal cancer.. Nature genetics. Abstract
Buchanan DD, Win AK, Walsh MD, Walters RJ, Clendenning M, Nagler BN, Pearson S-A, Macrae F, Parry S, Arnold J et al..  2013.  Family History of Colorectal Cancer in BRAF p.V600E mutated Colorectal Cancer Cases.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP, Winship IM, Arnold J, Ahnen DJ, Haile RW et al..  2015.  Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.. JAMA. 314(1):61-71. Abstract
Lindor NM, Larson MC, Derycke MS, McDonnell SK, Baheti S, Fogarty ZC, Win AK, Potter JD, Buchanan DD, Clendenning M et al..  2016.  Germline miRNA DNA Variants and the Risk of Colorectal Cancer by Subtype.. Genes, chromosomes & cancer. Abstract
Rosty C, Clendenning M, Walsh MD, Eriksen SV, Southey MC, Winship IM, Macrae FA, Boussioutas A, Poplawski NK, Parry S et al..  2016.  Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort.. BMJ open. 6(2):e010293. Abstract
Yurgelun MB, Masciari S, Joshi VA, Mercado RC, Lindor NM, Gallinger S, Hopper JL, Jenkins MA, Buchanan DD, Newcomb PA et al..  2015.  Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.. JAMA oncology. 1(2) Abstract
Salomon MP, Li WLS, Edlund CK, Morrison J, Fortini BK, Win AK, Conti DV, Thomas DC, Duggan D, Buchanan DD et al..  2016.  GWASeq: targeted re-sequencing follow up to GWAS.. BMC genomics. 17(1):176. Abstract
Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA et al..  2012.  Identification of Lynch syndrome among patients with colorectal cancer.. JAMA : the journal of the American Medical Association. 308(15):1555-65. Abstract
Derycke MS, Gunawardena SR, Middha S, Asmann YA, Schaid DJ, McDonnell SK, Riska SM, Eckloff BW, Cunningham JM, Fridley BL et al..  2013.  Identification of Novel Variants in Colorectal Cancer Families by High-Throughput Exome Sequencing.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Whiffin N, Hosking F, Farrington SM, Palles C, Dobbins S, Zgaga L, Lloyd A, Kinnersley B, Gorman M, Tenesa A et al..  2014.  Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.. Human molecular genetics. Abstract